Walleye Capital’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,583
Closed -$232K 5228
2026
Q1
$232K Sell
1,583
-24,910
-94% -$3.84M ﹤0.01% 3246
2025
Q4
$4.1M Buy
26,493
+25,659
+3,077% +$3.84M 0.01% 1300
2025
Q3
$116K Buy
+834
New +$113K ﹤0.01% 3635
2025
Q2
Sell
-23,027
Closed -$3.11M 5115
2025
Q1
$3.36M Sell
23,027
-71,928
-76% -$10.4M 0.02% 1059
2024
Q4
$13.1M Buy
94,955
+85,913
+950% +$12.6M 0.03% 487
2024
Q3
$1.39M Buy
9,042
+7,030
+349% +$1.07M ﹤0.01% 2310
2024
Q2
$293K Sell
2,012
-1,488
-43% -$213K ﹤0.01% 3993
2024
Q1
$517K Buy
+3,500
New +$502K ﹤0.01% 3160
2023
Q1
Sell
-52,641
Closed -$7.15M 4430
2022
Q4
$7.15M Buy
+52,641
New +$6.98M 0.13% 188
2022
Q3
Sell
-21,693
Closed -$2.78M 3598
2022
Q2
$2.78M Sell
21,693
-33,452
-61% -$4.38M 0.08% 281
2022
Q1
$7.55M Buy
+55,145
New +$7.3M 0.2% 119

Other funds holding XLV

Walleye Capital's XLV Position: Q2 2026 in Review

Walleye Capital sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q2 2026, closing a stake of 1,583 shares — an estimated $232K sold.

Walleye Capital first reported a position in XLV in Q1 2022 and held it in 11 quarters. The position peaked at $13.1M in Q4 2024. 1,861 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Walleye Capital reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 1,583 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $232K.
  • Walleye Capital first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2022 and held it in 11 quarters.
  • Walleye Capital's State Street Health Care Select Sector SPDR ETF position peaked at $13.1M in Q4 2024.
  • 1,861 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.